Pentraxin 3 as biomarker
General Methods in Biomarker Research and their Applications, ISSN: 2542-3657, Vol: 1-2, Page: 267-290
2015
- 1Citations
- 4Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Pentraxin 3 (PTX3), a member of the pentraxin superfamily, contains the HxCxS/ TWxS pentraxin signature. It is produced by endothelial cells, smooth muscle cells, fibroblasts, adipocytes, dendritic cells, and macrophages in various tissues in response to the different stimulants including inflammatory signals, Toll-like receptor activation, microbial moieties, or microorganisms. PTX3 has the abilities to interact with several ligands. PTX3 has significant biological roles in the inflammation, the immune system, apoptosis, angiogenesis, and restenosis, and maturation of oocytes. BloodPTX3levels are reliable predicted long-termmortality. PTX3 levels have been shown to be an independent marker of disease activity. Recently reported translational studies suggest that PTX3 may be a useful biomarker of various human diseases. In particular, the combination of PTX3 and classical biomarkers provides more diagnostic and prognostic value in several clinical conditions, including sepsis, infectious diseases, acute coronary syndrome, and chronic kidney disease. PTX3may be a novel, promising biomarker that provides useful prognostic information for clinical outcomes in different pathological conditions.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84958683777&origin=inward; http://dx.doi.org/10.1007/978-94-007-7696-8_3; https://link.springer.com/10.1007/978-94-007-7696-8_3; https://dx.doi.org/10.1007/978-94-007-7696-8_3; https://link.springer.com/referenceworkentry/10.1007/978-94-007-7696-8_3
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know